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Abstract
Background
Taenia solium cysticercosis is a zoonotic neglected disease responsible for severe health
disorders such as seizures and death. Understanding the epidemiology of human cysticer-
cosis (HCC) in endemic regions will help to expose critical information about the transmis-
sion of the disease, which could be used to design efficient control programs. This review
gathered serological data on apparent prevalence of T. solium circulating antigens and/or
seroprevalence of T. solium antibodies, apparent prevalence of human taeniasis and risk
factors for HCC from endemic communities in order to understand the differences in expo-
sure to the parasite and active infections with T. soliummetacestodes in endemic areas
around the world.
Methods
Three databases were used to search sero-epidemiological data from community-based
studies conducted between 1989 and 2014 in cysticercosis endemic communities world-
wide. The search focused on data obtained from T. solium circulating antigen detection by
monoclonal antibody-based sandwich ELISA and/or T. solium antibody seroprevalence
determined by Enzyme-linked Immunoelectrotransfer Blot (EITB). A meta-analysis was per-
formed per continent.
Principal Findings
A total of 39,271 participants from 19 countries, described in 37 articles were studied. The
estimates for the prevalence of circulating T. solium antigens for Africa, Latin America and
Asia were: 7.30% (95% CI [4.23–12.31]), 4.08% (95% CI [2.77–5.95]) and 3.98% (95% CI
[2.81–5.61]), respectively. Seroprevalence estimates of T. solium antibodies were 17.37%
(95% CI [3.33–56.20]), 13.03% (95% CI [9.95–16.88]) and 15.68% (95% CI [10.25–23.24])
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003919 July 6, 2015 1 / 20
OPEN ACCESS
Citation: Coral-Almeida M, Gabriël S, Abatih EN,
Praet N, Benitez W, Dorny P (2015) Taenia solium
Human Cysticercosis: A Systematic Review of
Sero-epidemological Data from Endemic Zones
around the World. PLoS Negl Trop Dis 9(7):
e0003919. doi:10.1371/journal.pntd.0003919
Editor: Paul Robert Torgerson, University of Zurich,
SWITZERLAND
Received: March 6, 2015
Accepted: June 17, 2015
Published: July 6, 2015
Copyright: © 2015 Coral-Almeida et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was financially supported by the
Belgian Cooperation in the framework of the
Institutional Collaboration between the Institute of
Tropical Medicine in Antwerp, Belgium and the
Centro Internacional de Zoonosis, Quito-Ecuador.
The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
respectively. Taeniasis reported prevalences ranged from 0 (95% CI [0.00–1.62]) to
17.25% (95% CI [14.55–20.23]).
Significance
A significant variation in the sero-epidemiological data was observed within each continent,
with African countries reporting the highest apparent prevalences of active infections. Intrin-
sic factors in the human host such as age and immunity were main determinants for the
occurrence of infections, while exposure was mostly related to environmental factors which
varied from community to community.
Author Summary
Human cysticercosis is a neglected zoonotic disease caused by the larval stage of the para-
site Taenia solium. This disease is responsible for severe health disorders such as seizures,
and in some cases even death. T. solium cysticercosis is endemic in countries in Africa,
Latin America and Asia where conditions such as inadequate hygiene, poor sanitary con-
ditions, open defecation, free roaming pigs and poverty permit the transmission of the dis-
ease. Diagnostic tools are capable of detecting exposure to eggs and infection levels in a
population through antibody and antigen detection, respectively. This review focused on
gathering epidemiological data from endemic communities in Africa, Latin America and
Asia in order to understand the causes of the observed variations in exposure/infection
patterns in endemic regions. Similar antibody seroprevalences were observed worldwide
while infection prevalences varied significantly within each region. Intrinsic factors such
as age and immunity were determining factors for the occurrence of infections, while
exposure was related to environmental factors which varied from region to region. Under-
standing the epidemiology of cysticercosis in endemic regions will help expose informa-
tion on the transmission, which could in turn be used to design appropriate control
programs.
Introduction
Taenia solium human cysticercosis (HCC) is a zoonotic parasitic disease causing severe health
and economic problems in endemic areas in Latin America, Africa and Asia [1–4]. The disease
is related to poor sanitary conditions, inadequate hygiene, open defecation, presence of free
roaming pigs and poverty [5;6]. The natural life cycle of T. solium includes humans as the only
definitive hosts carrying the intestinal adult tapeworm, and pigs as the intermediate hosts
infected with the metacestode larval stage (cysticercus), generally in the muscular tissue.
Humans acquire a T. solium tapeworm infection (taeniasis) by consumption of undercooked
pork containing viable cysticerci. Pigs contract porcine cysticercosis (PCC) by ingestion of via-
ble T. solium eggs contained in feces from human tapeworm carriers. HCC occurs when
humans accidentally ingest T. solium eggs and develop the larval stage of T. solium in different
tissues. Once established in the tissue of the intermediate host, the cysticercus develops into the
viable stage, which is composed of a scolex visible through vesicular fluid and an opaline mem-
brane inside a cyst [7]. After a few months or years, depending on the host immune response,
the cysticercus starts degenerating, the vesicular fluid becomes dense and opaque, the cyst loses
also its regular shape and becomes smaller. Finally, the cysticercus undergoes the stage of
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calcification in which it ends as a round white calcified nodule [8]. Neurocysticercosis (NCC)
occurs when the larval stage establishes in the central nervous system [9]. NCC is the most
severe presentation of the infection and is considered the most important parasitic disease of
the neural system, being responsible for almost one third of the acquired epilepsy cases in
endemic areas [2]. HCC can also involve muscular and ocular disorders, infection of subcuta-
neous tissue [10–12] and in severe cases can even cause death [13]. Even though HCC is con-
sidered potentially eradicable, it is still highly prevalent in developing countries [14]. Different
intervention measures have to be integrated to interrupt transmission of T. solium. Effective
control programs will reduce the incidence and prevalence of the disease leading to acceptable
and manageable levels, which could therefore become a first step towards elimination and
eradication of the disease. Understanding the conditions for transmission is required for devel-
oping appropriate interventions [15]. This mainly involves accurate estimations of exposure
and infection patterns in communities, which can be obtained by laboratory tests [15;16]. Cur-
rent immunological tools used in HCC diagnosis can be classified into: 1) Tests detecting anti-
bodies directed against T. solium cysticerci, identifying exposure to the parasite, and 2) Tests
detecting circulating antigens produced by living cysticerci, identifying current infection with
viable cysticerci [17]. Measuring the level of adult tapeworm infections in a population can be
used as a support for results obtained from immunological tests to measure exposure. To
understand exposure and infection patterns it is also important to have a correct interpretation
of risk factors, information that can be provided by studying the correlation between host,
environment and parasite factors and serological results for cysticercosis.
Similar sero-epidemiological studies conducted in two endemic communities in Africa and
Latin America, presented comparable serological results for exposure to T. solium eggs with
exposure levels of 34.55% and 31.22%, respectively but presented significant differences when
reporting active infections with almost 12 times more infections in the African than in the
Latin American community [16;18], suggesting that there were significant variations in the
conditions for transmission and in the establishment of infection in each community. For this
reason, extrapolating results from a single community to a regional or even global level can be
a hazardous exercise.
The aim of this review is to systematically collect serological data on apparent prevalence of
T. solium circulating antigens and/or seroprevalence of T. solium antibodies, apparent preva-
lence of human taeniasis and risk factors for HCC from endemic communities in order to
understand the differences in exposure to the parasite and active infections with T. solium
metacestodes in endemic areas around the world.
Methods
A systematic literature search on T. solium HCC seroprevalence in community-based studies
performed in endemic countries in Africa, Asia, Latin America and the Caribbean was con-
ducted on indexed literature published during the period from 1989 to 2014. In order to have
comparable data, this search focused on the articles in which data was obtained using the fol-
lowing techniques and protocols: 1) Enzyme-linked Immunoelectrotransfer Blot (EITB) from
Tsang et al. (1989) [19] for detection of antibodies directed against seven specific glycoproteins
from T. soliummetacestodes and/or 2) Enzyme Linked Immunosorbent Assay detecting circu-
lating antigens from the T. soliummetacestode (B158/B60 Ag-ELISA or HP10 Ag-ELISA)
from Brandt et al. (1992) [20], Van Kerckhoven et al. (1998) [21], Dorny et al. (2000) [22] and
Harrison et al. (1989) [23]. Selection was restricted to both EITB and Ag-ELISA because of
their performance, frequent use and acceptance as highly sensitive and specific tests in commu-
nity-based studies when compared to other techniques. The EITB has a sensitivity ranging
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from 97 to 98% and a specificity ranging from 97 to 100% to detect circulating antibodies to T.
solium in human serum. The EITB is considered positive when at least one of the seven specific
glycoproteins from T. soliummetacestodes is recognized by the serum The B158/B60 Ag-
ELISA has a sensitivity of 90% (95% CI:[80–99%]) and a specificity of 98% (95% CI:[97–99%])
to detect circulating antigens released by T. soliummetacestodes in humans, with no cross-
reactions reported to date [17;19;24]. For the HP10 Ag-ELISA the reported sensitivity ranges
from 84.8% to 86% and the specificity is estimated at 94% to detect circulating antigens in
human serum [25;26]. For the studies where the EITB was performed, either the Centers for
Disease Control and Prevention (CDC) test or commercial kits were accepted for selection.
Taeniasis apparent prevalence data was collected when available in the selected articles and no
restrictions for the diagnostic method was made. It was anticipated that the taeniasis data
would be influenced by the technique used because coprology, coproantigen ELISA and molec-
ular methods have wide differences in their diagnostic performances. The estimated sensitivi-
ties of these tests were: 52.5% (95% CI:[11.1–96.5]) for coprology, 84.5% (95% CI:[61.9–98])
for coproantigen ELISA and 82.7% (95% CI:[57–97.6]) for real-time polymerase chain reaction
assay (copro-PCR) and their specificities were: 99.9% (95% CI:[99.5–100]) for coprology, 92%
(95% CI: [90–93.8]) for coproantigen ELISA and 99% (95% CI:[98.2–99.6]) for copro-PCR
[27]. The wide confidence interval for the estimated value for the sensitivity of coprology is due
to the low number of positive cases found by this method, which does not allow a more accu-
rate estimation, however is in line with previous studies [28–30]. Language restriction was
applied when the article was written in a language other than those spoken or understood by
the authors of this review. The considered languages were English, Spanish, French, Portuguese
and Dutch.
The selected databases for this study were: PubMed (http://www.ncbi.nlm.nih.gov/pubmed/),
LILACS (Latin American and Caribbean Health Sciences Literature, lilacs.bvsalud.org/en/) and
Web Of Science (http://wok.mimas.ac.uk/). The search was performed from September 1st 2013
until October 31st 2014.
Search
The following search strategy was applied: In PubMed, using the Boolean operator AND, the
terms “cysticercosis” AND “Taenia solium” AND “epidemiology” were introduced in the main
search bar and the filters were activated for the period from 1988/12/31 to 2014/10/31. In Web
of Science, the strategy applied was introducing in the basic search bar the topic “cysticercosis”
adding fields with the correspondent Boolean operators: AND Topic = (Taenia solium) AND
Topic = (epidemiology). In LILACS, the strategy adopted consisted in introducing in the main
search bar the terms “cysticercosis Taenia solium”. In the latter case the term “epidemiology”
was excluded to obtain the maximum return of articles since LILACS is a smaller targeted data-
base when compared to PubMed and Web Of Science. Additionally, relevant articles were
included that were not found with this search strategy but matched the selection criteria after
manual search or expert recommendation.
Study selection
The articles were selected following three phases: The first phase consisted in the removal of all
repeated studies from the title selection and all studies performed before 1989. The second
phase consisted in the exclusion of articles from the title and abstract review as for the follow-
ing exclusion criteria: 1) Wrong parasite species, 2) Studies performed in non-endemic coun-
tries, 3) Studies performed only in animals, 4) Clinical studies, 5) Studies which focused only
on human taeniasis, 6) Studies carried out for assessing laboratory tests performance, 7)
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Studies that focused on NCC, 8) Studies conducted in specific targeted types of individuals (e.g.
schoolchildren, refugees or soldiers), 9) Articles written in languages other than those spoken
or understood by the authors of this review, 10) Interviews, letters, reviews or editorials not
presenting original data and/or the techniques and protocols performed on their studies, 11)
Studies not related to T. solium epidemiology. The third phase was applied when full texts were
read and consisted in the study selection according to the following selection criteria: 1) Com-
munity-based studies, 2) Original HCC prevalence reports available, 3) Protocols applied for
HCC diagnosis using the EITB and Ag-ELISA protocols mentioned previously in this docu-
ment, 4) Random sampling method for selection of participants in the study or/and population
representative voluntary participation. 5) Coverage of most age groups (young, adults and
elderly).
Data collection
From every selected article the following items were collected and introduced in a data base:
Author(s), year the article was published, country, number of participants for Ag-ELISA sur-
vey, number of Ag-ELISA positive detected cases, number of participants for EITB survey,
number of EITB positive detected cases (when specified in the article, the EITB positive cases
were considered when at least one band had a visible reaction [19]), estimated apparent preva-
lence expressed in percentage. When applicable, identified risk factors were also included in
the database. For longitudinal studies where two or more sampling rounds were organized in a
community, only data from the first round were taken into account in order to avoid any possi-
ble bias caused after contact with the teams collecting the samples. Additionally, if the study
was conducted in parallel with a survey on human taeniasis, the prevalence and the method
used to diagnose taeniasis were also gathered. All countries where the selected studies took
place were visualized using QGIS software (version2.8).
Statistical analysis
Ameta-analysis was conducted using the “meta” package in R [31] to estimate the prevalence
of circulating antigens for T. solium and the seroprevalence of antibodies in each continent
based on a random effects model. A global prevalence estimation was not performed as it was
not the intention of this study. Ninety five % exact binomial Confidence Intervals (95% CI)
were calculated for every reported prevalence. The significant differences in estimated preva-
lences were evaluated using their 95% confidence intervals. The difference in prevalence
between two regions was considered to be statistically significant if their 95% confidence inter-
vals do not overlap.
Results
Study selection
Fig 1 describes the review process and the number of articles selected at each stage of the
review. From an initial number of 696 articles, only 37 studies were included in this review; 9
studies were selected for the African region [18;32–39], 22 studies for Latin America [16;40–
60] and 6 for the Asian region.
Human cysticercosis in Africa
From the 9 sero-epidemiological studies from 7 countries selected for the African region, 7
studies [32–34;36–39] used Ag-ELISA and two studies [18;35] used both Ag-ELISA and EITB.
The total number of individuals sampled for serological testing in this region was 12,596.
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Prevalence of circulating antigens ranged from 0.68% to 21.63%, while seroprevalence of anti-
bodies ranged from 7.69 to 34.55%. Detailed descriptions of each study are given in Table 1.
Fig 1. Flow diagram describing literature search and selection of studies (PRISMA 2009 flow chart).
doi:10.1371/journal.pntd.0003919.g001
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Human cysticercosis in Latin America
Information on HCC in Latin America was obtained from 22 studies from 8 countries with
two studies performing only Ag-ELISA [44;55], 17 studies performing EITB only [40–43;45–
54;57–59] and three studies performing both Ag-ELISA and EITB [16;56;60]. The total number
of individuals sampled was 21,911. Active T. solium infection ranged from 0.94 to 9.12% and
antibody seroprevalence ranged from 1.82 to 31.22%. A detailed description of each study is
given in Table 2.
Human cysticercosis in Asia
The data obtained for HCC in Asia resulted from 6 studies from 4 countries organized in 4
studies performing Ag-ELISA only [24;61–63], one study performing EITB only [64] and one
study performing both Ag-ELISA and EITB [65]. The total number of individuals sampled was
4,764. Seroprevalence varied from 0.57 to 5.71% for circulating T. soliummetacestode antigens
and from 12.60 to 19.17% for T. solium antibody seroprevalence. Detailed descriptions of each
study are given in Table 3.
Globally, 39,271 participants from 19 countries were included in 37 studies, from which
24,467 were studied for circulating T. solium antigen with 5.52% (1,351/24,467) positive cases
Table 1. Sero-epidemiological studies using Ag-ELISA and/or EITB for human cysticercosis in Africa.
Author YOP Country Location Circulating Ag
positive cases/total
participants
Circulating Ag
prevalence (%)
[95%CI]
Ab positive cases/
total participants
Ab seroprevalence
(%) [95%CI]
Nguekam
et al.
2003 Cameroon West province 34a/4993 0.68 [0.47–0.95]
Carabin
et al.
2009 Burkina Faso Sanguié,
Kadogo,
Oubritenga
48a/763 6.29 [4.67–8.25]
Kanobana
et al.
2011 Dem. Rep. of
Congo
Bas-Congo 204a/943 21.63 [19–24.4]
Secka et al. 2011 Senegal Ziguinchor 31a/403 7.69 [5.28–10.74] 31/403 7.69 [5.28–10.74]
Nitiéma
et al.
2012 Burkina Faso Sanguié,
Kadogo,
Oubritenga
45a/734 6.13 [4.50–8.12]
Mwape
et al.
2012 Zambia Estern Province 41a/707 5.80 [4.19–7.8]
Mwape
et al.
2013 Zambia Eastern
Province
141a/1129 12.49 [10.61–14.56] 57/165 34.55 [27.32–47.33]
Mwanjali
et al.
2013 Tanzania Mbeya 139a/830 16.75 [14.27–19.46]
Thomas 2014 Kenya Western and
Nyanza
169b/2094 8.07 [6.94–9.32]
Total 852/12596 6.76 [6.33–7.22] 88/568 15.49 [12.61–18.73]
REMEP: 7.30 [4.23–12.31] 17.37 [3.33–56.20]
Legend: YOP: Year of publication; Location: Corresponds to the Province, State, Region or Department in which the communities where the studies took
place are located; Ag: Antigen detection based on Ag-ELISA results; Ab: Antibody detection based on EITB results; 95% CI: 95% Conﬁdence Intervals;
REMEP: Random Effects Model Estimated Prevalence; Dem. Rep. of Congo: Democratic Republic of Congo.
a: Results obtained from B158/B60 Ag-ELISA
b: Results obtained from HP10 Ag-ELISA.
doi:10.1371/journal.pntd.0003919.t001
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(95% CI [5.24–5.82]) and 18,643 were studied for anti T. solium antibodies with a crude sero-
prevalence of 14.20% (2,648/18,643) (95% CI [13.70–14.71]). Fig 2 represents the global distri-
bution of the countries where the serological studies took place.
Table 2. Sero-epidemiological studies using Ag-ELISA and/or EITB for human cysticercosis in Latin America.
Author YOP Country Location Circulating Ag positive
cases/Total
participants
Circulating Ag
Prevalence (%)
[95%CI]
Ab positive cases/
Total participants
Ab seroprevalence
(%) [95%CI]
Díaz et al. 1992 Peru San Martin 30/371 8.09 [5.52–11.34]
Sarti et al. 1992 Mexico Morelos 167/1546 10.80 [9.3–12.46]
Sarti et al. 1994 Mexico Michoacan 49/1005 4.88 [3.63–6.39]
García-Noval
et al.
1996 Guatemala Jutiapa 207/1542 13.42 [11.76–15.23]
Sanchez et al. 1998 Honduras Francisco
Morazán
63/404 15.59 [12.2–19.5]
García et al. 1998 Peru Cusco 24/102 23.8 [15.69–32.96]
Sanchez et al. 1999 Honduras Olancho 80/480 16.67 [13.44–20.31]
García et al. 1999 Peru Cusco 14/108 12.96 [7.27–20.8]
Sarti et al. 2000 Mexico Morelos 91/1603 5.68 [4.59–6.92]
García et al. 2001 Peru Piura 76/482 15.77 [12.63–19.33]
Peru Junín 140/398 35.18 [30.48–40.1]
Colombia N.A. 23/750 3.07 [1.95–4.57]
Gomes et al. 2002 Brazil Bahia 11/694 1.59 [0.79–2.82]
García et al. 2003 Peru Junín 355/2583 13.74 [12.44–15.13]
Ferrer et al. 2003 Venezuela Carabobo 27b/296 9.12 [6.10–12.99]
Venezuela Lara 37b/608 6.08 [4.32–8.29]
Venezuela Lara 20b/305 6.56 [4.05–9.95]
Agudelo-Flores
& Palacio
2003 Colombia Antioquia 12/661 1.82 [0.94–3.15]
Moro et al. 2003 Peru Lima 66/316 20.89 [16.54–25.79]
Rodriguez
et al.
2003 Ecuador Pichincha &
Imbabura
215a/4306 4.99 [4.36–5.69]
Montano et al. 2005 Peru Tumbes 200/825 24.24 [21.35–27.32]
Rodriguez
et al.
2006 Ecuador Loja 18a/800 2.25 [1.34–3.53] 40/100 40.00 [30.33–50.23]
Agudelo-Flores
et al.
2009 Colombia Chocó 4/46 8.70 [2.42–20.79]
Lescano et al. 2009 Peru Tumbes 196/803 24.41 [21.47–27.53]
Praet et al. 2010 Ecuador Loja 23a/794 2.90 [1.84–4.31] 202/807 25.03 [22.08–28.17]
Coral et al. 2014 Ecuador Loja 7a/744 0.94 [0.38–1.93] 232/743 31.22 [27.9–34.69]
Total 347/7853 4.42 [3.97–4.90] 2282/16369 13.94 [13.41–14.48]
REMEP: 4.08 [2.77–5.95] 13.03 [9.95–16.88]
Legend: YOP: Year of publication; Location: Corresponds to the Province, State, Region or Department in which the communities are located where the
studies took place; Ag: Antigen detection based on Ag-ELISA results; Ab: Antibody detection based on EITB results; 95% CI: 95% Conﬁdence Intervals;
REMEP: Random Effects Model Estimated Prevalence
a: Results obtained from B158/B60 Ag-ELISA
b: Results obtained from HP10 Ag-ELISA
N.A.: Not available.
doi:10.1371/journal.pntd.0003919.t002
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Taeniasis
Within the examined reports, twenty-four studies from 14 countries in Africa (6 studies), Latin
America (13 studies) and Asia (5 studies) reported adult T. solium data, using different diag-
nostic techniques. In these studies, 4,682 African, 13,782 Latin American and 3,437 Asian sub-
jects participated; with a global participation of 21,901 individuals. Apparent prevalence on
taeniasis varied from 0 to 17.25%. Results are shown in Table 4.
Risk factors for human cysticercosis
Twenty-three articles out of the 37 selected articles reported statistically significant risk factors
for the presence of T. solium circulating antigens or T. solium antibodies. The identified risk
factors for the presence of T. solium circulating antigens in Africa were: insufficient latrines
or sanitary toilets [35], washing hands by dipping method [67], history of taeniasis or
proximity to tapeworm carriers [37;39], being male [36] and increased risk with age [18;32;35–
37;39], while the identified risk factors for presence of anti T. solium antibodies were: insuffi-
cient latrines or sanitary toilets, and increased risk with age [35]. In Latin America the only
identified risk factor for presence of T. solium circulating antigens was associated with
increased age [60], while the identified risk factors for presence of T. solium antibodies were:
insufficient latrines or sanitary toilets [45;53;59], lack of potable water [45], poor personal
hygiene [41], deficient house hygiene [41], earthen floor [45], presence of infected pigs [48;52],
pig owning [45;52;53;59], pork consumption [41;59], history of taeniasis/proximity to tape-
worms carriers [41;43;51;52;58], being female [43;46;59], age (risk increased with age)
[16;40;42;57;60], increased risk at younger age [54], low education level [45;54], presence of a
sewage system [57]. In Asia the only risk factor for the presence of T. solium circulating anti-
gens was the ownership of pigs [62].
Table 3. Sero-epidemiological studies using Ag-ELISA and/or EITB for human cysticercosis in Asia.
Author YOP Country Location Circulating Ag
positive cases/total
participants
Circulating Ag
prevalence (%)
[95%CI]
Ab positive
cases/total
participants
Ab seroprevalence
(%) [95%CI]
Theis et al. 1994 Indonesia Bali 94/746 12.60 [10.3–15.2]
Erhart et al. 2002 Viet Nam Bac Ninh 12a/210 5.71 [2.99–9.77]
Somers et al. 2006 Viet Nam Bac Kan 16a/303 5.28 [3.05–8.43]
Viet Nam Ha Tinh 1a/175 0.57 [0.01–3.14]
Raghava et al. 2010 India Tamil Nadu 46a/960 4.79 [3.53–6.34] 184/960 19.17 [16.72–21.8]
Jayaraman
et al.
2011 India Tamil Nadu 48a/1064 4.51 [3.34–5.94]
Conlan et al. 2012 Laos Oudomxay,
Luangprabang,
Huaphan, and
Xiengkhuang
29a/1306 2.22 [1.49–3.17]
Total 152/4018 3.78 [3.21–4.42] 278/1706 16.29 [14.57–18.13]
REMEP 3.98 [2.81–5.61] 15.68 [10.25–23.24]
Legend: YOP: Year of publication; Location: Corresponds to the Province, State, Region or Department in which the communities are located where the
studies took place; Ag: Antigen detection based on Ag-ELISA results; Ab: Antibody detection based on EITB results; 95% CI: 95% Conﬁdence Intervals;
REMEP: Random Effects Model Estimated Prevalence
a: Results obtained from B158/B60 Ag-ELISA
doi:10.1371/journal.pntd.0003919.t003
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Meta-analysis
The random effects model used in the meta-analysis gave an overall estimated prevalence for
circulating T. solium antigens in Africa of 7.30% (95% CI [4.23–12.31]) from 9 studies. The
overall estimated prevalence for circulating T. solium antigens in Latin America was 4.08%
(95% CI [2.77–5.95]) from 5 studies and 3.98% (95% CI [2.81–5.61]) for Asia from 5 studies.
For the anti T. solium antibodies seroprevalence, the overall estimated seroprevalence in Africa
was 17.37% (95%CI [3.33–56.20]) from 2 studies, while in Latin America it was 13.03% (95%
CI [9.95–16.88]) from 20 studies and in Asia 15.68% (95% CI [10.25–23.24]) from 2 studies.
The prevalence of circulating T. solium antigens was not significantly different between conti-
nents and neither was the anti T. solium antibodies seroprevalence. The prevalence of circulat-
ing T. solium antigens was significantly lower than the T. solium antibodies seroprevalence in
Latin America and Asia but not in Africa.
Discussion
The results of this review allowed us to characterize and compare estimates of active infections
with T. soliummetacestodes and exposure to the parasite in endemic communities of different
countries in three continents. The estimated seroprevalence of anti T. solium antibodies in
Africa (17.37%), Latin America (13.03%) and Asia (15.68%) was not significantly different,
Fig 2. Global distribution of the endemic countries where Ag-ELISA and/or EITB based epidemiological studies were held. Light yellow represents
the countries confirmed as endemic by theWorld Health Organization (WHO) until 2012 [66]. Circles represent the countries where Ag-ELISA based studies
took place. Each color represents the average prevalence per country found from the selected articles in this review classified in 0 to 5 percent; 5 to 10
percent and more than 10 percent. Triangles represent the countries where EITB based studies took place. Each color represents the average prevalence
per country found from the selected articles in this review classified in 0 to 5 percent; 5 to 10 percent and more than 10 percent.
doi:10.1371/journal.pntd.0003919.g002
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Table 4. Taeniasis reports from Africa, Latin America and Asia.
Continent Author Year of
publication
Country Diagnostic Technique Positive cases/ Total
participantsa
Prevalence (%)
[95%CI]
Africa Kanobana
et al.
2011 Dem. Rep. of
Congo
Coprology† 3/816 0.37 [0.08–1.07]
Secka et al. 2011 Senegal Direct fecal examination 2/43** 4.65 [0.57–15.81]
FECT 4/43** 9.30 [2.59–22.14]
worm expulsion and
morphological identiﬁcation
1/43** 2.33 [0.06–12.29]
Mwape et al. 2012 Zambia FECT 2/718 0.28 [0.03–1.00]
Copro-Ag ELISA 45/712 6.32 [4.65–8.37]
Mwanjali et al. 2013 Tanzania Copro-Ag ELISA 43/820 5.24 [3.82–7.00]
EITB (rES38) 34/820 4.15 [2.89–5.75]
FECT 9/820 1.10 [0.50–2.07]
Mwape et al. 2013 Zambia FECT 0/226 0.00 [0.00–1.62*]
Copro-Ag ELISA 27/226 11.95 [8.02–16.90]
Thomas 2014 Kenya Copro-Ag ELISA 278/2003 13.88 [12.39–
15.47]
FECT 4/2059 0.19 [0.05–0.50]
Latin
America
Diaz et al. 1992 Peru microscopy, both directly and
after FECT
1/305 0.33 [0.01–1.81]
Sarti et al. 1992 Mexico FECT 4/1531 0.26 [0.07–0.67]
Sarti et al. 1994 Mexico FECT 2/828 0.24 [0.03–0.87]
García-Noval
et al.
1996 Guatemala FECT & Copro-Ag ELISA 27/995 2.71 [1.80–3.92]
Guatemala FECT& Copro-Ag ELISA 123/713 17.25 [14.55–
20.23]
Sanchez et al. 1998 Honduras FECT 2/404 0.50 [0.06–1.78]
Sanchez et al. 1999 Honduras FECT 12/480 2.50 [1.30–4.33]
Sarti et al. 2000 Mexico Copro-Ag ELISA 16/1865 0.86 [0.49–1.39]
FECT 11/1865 0.59 [0.29–1.05]
Gomes et al. 2002 Brazil Copro-Ag ELISA 26/577 4.51 [2.96–6.53]
Rodriguez
et al.
2003 Ecuador FECT 30/1935 1.55 [1.05–2.21]
PCR-RFLP (identiﬁcation) 8/29 27.59 [12.73–
47.24]
García et al. 2003 Peru microscopy, both directly and
after FECT
8/1317 0.61 [0.26–1.19]
Copro-Ag ELISA 45/1619 2.78 [2.03–3.70]
Lescano et al. 2009 Peru FECT 11/898 1.22 [0.61–2.18]
Praet et al. 2010 Ecuador FECT 0/674 0.00 [0.00–0.55*]
MSFT 0/674 0.00 [0.00–0.55*]
Rodriguez
et al.
2006 Ecuador FECT 14/958 1.46 [0.80–2.44]
PCR-RFLP (identiﬁcation) 12/12 100 [73.54–100*]
Asia Erhart et al. 2002 Viet Nam FECT 0/210 0.00 [0.00–1.74*]
Somers et al. 2006 Viet Nam Copro-Ag ELISA 1/297 0.34 [0.01–1.86]
KATO 1/297 0.34 [0.01–1.86]
Worm expulsion & PCR-RFLP
for identiﬁcation
1/297 0.34 [0.01–1.86]
Viet Nam Copro-Ag ELISA 3/166 1.81 [0.37–5.19]
KATO 2/166 1.20 [0.15–4.28]
(Continued)
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which could be interpreted as a similar exposure to T. solium eggs in these regions, though,
within each continent a visible heterogeneity was observed, with seroprevalence for antibodies
ranging from 1.82% to 40% as shown in Tables 1, 2 and 3.
The estimated prevalence of T. solium circulating antigens was higher in endemic areas of
Africa (7.30%) compared to Latin America and Asia (4.08% and 3.98%, respectively), though
this difference was not statistically significant. When studied in detail, all the African studies
but one showed a higher prevalence of active infections than the studies in Latin America and
Asia: the prevalence of circulating antigens reported in Latin America and Asia ranged from
0.57 to 9.12%, while the prevalence in Africa ranged from 6.13 to 21.63%, excluding one study
fromWest Cameroon in 2003 reporting a prevalence of 0.68% [32]. The figures observed in
Tables 1, 2 and 3 demonstrate big variations in prevalence of active infection with T. solium
cysticerci, similar as observed for sero-prevalence of antibodies.
Studies from the Democratic Republic of Congo, Zambia and Tanzania [18;36;39] revealed
very high prevalence figures of circulating antigens not registered in any other part of the
world (21.63%, 12.49% and 16.75%, respectively). These figures suggest a higher occurrence of
HCC in Africa when compared to Latin America and Asia. The estimated prevalence of T.
solium circulating antigens in each continent was lower than the estimated seroprevalence for
T. solium antibodies in the same continent, but this difference was only statistically significant
for Latin America and Asia and not for Africa.
In studies that carried out both antigen and antibody detection tests [16;18;56;60;65] a sig-
nificantly higher seroprevalence of T. solium antibodies was observed (Tables 1, 2 and 3) except
for one study performed in Senegal [35] in which the number of positive cases for Ag-ELISA
and the number of EITB positive cases were similar. However, in that study only a fraction of
the positive cases was positive in both tests. This marked difference in the prevalence of circu-
lating antigens and of antibodies has already been observed by Praet et al. (2010) [17]: exposure
expressed by antibody seroprevalence could be interpreted as the result of a past infection, cur-
rent infection or the result of a failed infection, while circulating antigens can only be detected
if viable cysticerci are present.
Findings in this review from sero-epidemiological studies have shown that T. solium trans-
mission varied from one geographical location to another, which raised several questions on
the causes of these differences. It is reasonable to think that the variations in the figures
Table 4. (Continued)
Continent Author Year of
publication
Country Diagnostic Technique Positive cases/ Total
participantsa
Prevalence (%)
[95%CI]
Worm expulsion and PCR-RFLP
for identiﬁcation
1/166 0.60 [0.01–3.31]
Raghava et al. 2010 India Copro-Ag ELISA 22/729 3.02 [1.90–4.53]
Jayaraman
et al.
2011 India Copro-Ag ELISA 6/729 0.82 [0.30–1.78]
Conlan et al. 2012 Laos FECT and self-report 110/1306 8.42 [6.97–10.06]
Legend: FECT: Formalin-ether concentration technique; KATO: Kato-Katz technique; MSFT: Magnesium sulphate ﬂotation technique; PCR-RFLP:
Polymerase chain reaction-restriction fragment length polymorphism; ELISA: Enzyme-Linked Immunosorbent Assay; Copro-Ag ELISA: Coproantigen
ELISA; EITB: Enzyme-linked Immunoelectrotransfer Blot; Dem. Rep. of Congo: Democratic Republic of Congo.
a: Fecal samples were provided voluntarily from participants when not speciﬁed otherwise
*: One sided 97.5% conﬁdence interval
**: Technique applied in fecal samples from seropositive subjects for T. solium antibodies or circulating antigens
Coprology†: Technique not deﬁned
doi:10.1371/journal.pntd.0003919.t004
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observed in this study could be the result of a combination of more than one element capable
of affecting the presence of T. solium cysticercosis in a zone, such as individual host characteris-
tics, parasite singularities and environmental properties each of them prone to change depend-
ing on the geographical situation. Table 5 summarizes the potential factors contributing to the
variations observed in serology from endemic communities.
In this review, age was reported as a significant risk factor both for the presence of circulat-
ing antigens and/or antibodies, studied reports are compatible with what is described in
Table 5. The effect of gender on prevalence is less clear: the studies in Latin America [43;46;59]
indicated female to be more likely to have antibodies, while in Africa, in one study, male were
more likely to present circulating antigens [36]. The effect of gender on transmission should be
further studied to determine whether there is a real difference in physiological gender suscepti-
bility to T. solium infections [79], or rather a difference associated with the role gender plays in
every culture, resulting in different exposure. It is clear that immunity plays a huge role in the
host susceptibility/resistance to the parasite but the underlying mechanisms are not well under-
stood. In some cases, the origin of the type of immune resistance/susceptibility present in a
population is characterized by the surrounding environment more than of an intrinsic factor
in the host. This is the case for low immunity related to the poor nutritive status, which could
be a consequence of poverty [37].
Surprisingly, only for the studies from Latin America included in this review, the presence
of pigs and the consumption of pork were identified as important risk factors for exposure. In
one study from Asia this risk factor was associated with the presence of circulating antigens. In
contrast, none on the African studies revealed an association between pig ownership and pork
consumption and infection or exposure. These results are compatible with the results from
Mwape et al. (2015) [81], reporting other risk factors as the number of inhabitants and age as
Table 5. Factors affecting serological variations of human cysticercosis infection and exposure to T. solium eggs.
Human host (Accidental
intermediate host)
Parasite (Taenia solium) Environment
Factors affecting exposure
in a population
Age (time exposed to the
parasite)[32]
Number of adult parasites present (tapeworm
carriers, hotspots) [58;68]
(Presence of detectable
antibodies)
Gender (Role played in different
cultures)
Number of eggs dispersed in the environment
[69;70]
Occupation Egg survival (egg viability) on climatic conditions:
Temperature, Humidity, seasonality[69;70]
Hygiene, sanitation, behavioral practices,
agricultural & cooking practices[41]
Area (endemic)
Factors affecting active
infections in a population
Age (Immunosenescence) [60] T. solium genotype: Asian or
African/Latin American) [71–73]
Egg survival (egg viability) on climatic conditions:
Temperature, Humidity, seasonality[69;70]
(Presence of circulating
antigens)
Gender (Hormonal proﬁle)[74] Presence of other Taenia species
(within host) [63;75]
Frequency and Intensity of exposure [68]
Ethnicity (Immune
characteristics) [10;74;76]
Presence of other Taenia species (cross-
resistance) [63;75]:
Nutritional status [37] Presence of other pathogens [37;77;78]
Acquired immunity [79]
Innate immunity [16;62;72]
Immune proﬁle [79;80]
Level of exposure
Presence of concurrent
infections [37;77;78]
doi:10.1371/journal.pntd.0003919.t005
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determinants when studying and ranking T. solium infections determinants by classification
trees. In fact, HCC is the result of the ingestion of eggs coming from tapeworm carriers that
could have acquired the adult tapeworm from pork meat either locally produced or transported
from other endemic regions [67], thus, presence of pigs in this case is not as relevant for HCC
transmission than the local prevalence of tapeworm carriers. HCC is considered a “clustered”
disease; some studies have pointed out the importance of the presence of tapeworm carriers in
a household triggering HCC in endemic and non-endemic communities[82;83]. Twenty three
out of 24 studies reporting taeniasis identified at least one tapeworm carrier, however the diver-
sity of methods used to diagnose taeniasis did not allow to make adequate comparisons
between studies, even more, parasitological tests are considered having a low sensitivity, sug-
gesting underestimation of the prevalences. Nevertheless, tapeworm carrier identification can
be an important tool to recognize endemicity, in a zone, to identify the sources of infection and
to support serological results.
Other important risk factors reported from Africa and Latin America were related to poor
sanitary conditions, the deficient handling of human feces, the presence or history of adult
tapeworms near the positive cases and low educational level. In the latter case, educational level
could be interpreted also as an indicator of rural environment and/or poor household income
in endemic communities. An interesting finding is the association of the presence of sewage
installations in the house and positivity to EITB in a village in northern Peru [57]. Usually, sew-
age systems could be interpreted as a sanitary improvement, but in the Peruvian study, sewage
installations were present only in some houses, which could result in the concentrated use of
hygienic systems, and if they are not handled properly, they can turn the house into a “hotspot”
for HCC [58].
Little is known about T. solium eggs survival in the environment. Some studies have been
done on related cestodes like Taenia saginata and Echinococcus spp. [69], however, extrapolat-
ing knowledge from those studies could result in inadequate interpretations because of biologi-
cal differences between these species. In addition, flies may play a role in the transmission of
eggs of some Taenia spp. [84;85]; in the case of T. solium, however, flies were found not to be
important because of the coprophagic behavior of pigs that left not enough time after defeca-
tion to allow flies to get impregnated with T. solium eggs[86]. Dung beetles were also shown to
carry infective T. solium eggs in their bodies making them capable of transmitting the parasite
[87;88]; however, ingestion of the beetles is needed for effective transmission of the parasite,
which makes this route of transmission more likely for porcine cysticercosis than for HCC.
Nevertheless, from the experiences acquired in these studies [69; 84–88], it is clear that climatic
factors have a direct impact on the viability of taeniids eggs. Thus climatic factors can have a
direct influence on the variations observed in the prevalence of active infections and exposure
to T. solium in different climatic settings.
The results observed in the studies performing both Ag-ELISA and EITB could be inter-
preted as indicating a higher occurrence of active infection in African communities, under a
similar exposure to the parasite, suggesting that in this continent there are factors enhancing
the human infection regardless of the level of exposure. At a population level, variations and
similarities in exposure could be the result of the environmental or behavioral conditions
enhancing or disfavoring egg dispersal and survival. The presence of circulating antigens at a
population level is the outcome of viable cysticerci, which reflects successful establishment of
infection after exposure to T. solium eggs. This would indicate exposure to infectious eggs and
human behavior ensuring the uptake of eggs. Another factor triggering infection is the contact
with a large number of eggs, increasing the probability of breaking the immune barrier raising
the chance of the cysticerci to establish. A high prevalence of active infections could be as well
an indicator of weak immune responses due to multiple factors as described in Table 5. Also,
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the level of active infections in a population could be inversely proportional to the level of
intrinsic factors in the human hosts permitting the presence of innate or acquired resistance to
the parasite.
To have a complete picture on the human-to-human transmission for T. solium cysticerco-
sis, more longitudinal studies should be carried out following strict protocols in order to make
them comparable. In the present review, only three studies were found that contributed inci-
dence data, two from the Latin American region [16;50] and one from the African region [18].
The results from Ecuador and Zambia [16; 18] reported at least one change between positivity
and negativity in their EITB for T. solium antibodies in 20–32% of the population studied at
one point during a year. For the circulating antigen detection, the percentage of subjects show-
ing a similar phenomenon was about 11.5% of the studied population in Zambia. These results
suggest that the number of subjects that are actually exposed to T. solium eggs or are infected
with cysticerci every year is higher than what is reported in prevalence studies. Incidence data
could help to explain the interactions of the different components for transmission and their
evolution over time. Data obtained from these studies contribute enormous knowledge on how
seroprevalence estimation is affected because of the dynamic nature of the infection and of the
presence of transient antibodies and possibly transient antigens. Studying the fluctuations of
the humoral response over time can also provide information about the level of individual sus-
ceptibility by measuring the establishment rate of cysticerci following infection [89].The infor-
mation obtained from longitudinal studies can also help deciding on the duration of control
programs to effectively have an impact in the reduction on the prevalence of the disease.
When designing control programs and strategies, the correct interpretation of exposure pat-
terns can show which factors affect the egg dispersal in the environment and to locate the
potential “hotspots”[58;82;83]. By doing so, it will provide the necessary information to create
targeted interventions to avoid the spread of the disease taking into account that these patterns
vary from one location to another [82;83]. Interpreting the different infection patterns
observed in every community will help to prioritize which strategy should be better adapted to
the demo-geographical setting in order to decrease the number of new negative health
outcomes.
Variations in exposure to the parasite and active infection with T. solium cysticerci in
endemic communities present a challenge when implementing control programs. For these
reasons, more studies searching in parallel the presence of antibodies directed against T. solium
metacestodes and the presence of circulating antigens need to be conducted in other endemic
communities around the world with detailed characteristics of potential risk factors. It is also
recommended that these studies be paired with the study of the adult T. solium prevalence that
can provide another element of the transmission of the parasite.
The main limitation of this study was the lack of a standardized protocol in community-
based studies, which made comparable data scarce [90;91]. Moreover, the reliance on only one
serological test (EITB or Ag-ELISA) in most of the current sero-epidemiological studies gives
only a partial view of the current status of T. solium infection/exposure in the communities in
which they were carried out. Another limitation is that B158/B60 Ag-ELISA and HP10 Ag-
ELISA have not been compared in human samples, which could lead to different results given
the fact that the monoclonal antibodies used are directed against different antigens in each test.
On the other hand, the large time period that elapsed (22 years from 1989 to 2014) between the
oldest and the most recent studies may also imply a certain bias in the health, sanitary and edu-
cational conditions that may have changed and may have had a direct impact on the T. solium
life cycle, thus affecting its transmission dynamics and prevalence. Another important draw-
back is the fact that not all the studies selected for this review reported the presence of adult
tapeworms. Additionally, the methods used in the studies reporting the presence of tapeworms
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were diverse and considered with a low sensitivity and specificity, complicating comparisons
between studies. Moreover, not all the studies presented details of the studied population such
as representativeness of each age group, health status or the presence of other pathogens that
could have interfered when characterizing and comparing prevalence figures.
In conclusion, this review demonstrated the variability on the occurrence of active T. solium
infections and exposure to the parasite in endemic zones with some African communities
reporting the highest prevalence levels for cysticercosis active infection around the world with
results bordering 20%. Several significant risk factors were listed for both active T. solium infec-
tions and exposure to the parasite, some of them being determinant depending on the geo-
graphical location, climatic, economic and socio-cultural conditions. The findings in this
review should be taken into account in order to help defining priority areas for intervention
and control of T. solium.
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